CHEBI:90962 - Utibron Neohaler

ChEBI IDCHEBI:90962
ChEBI NameUtibron Neohaler
Stars
DefinitionA two-drug mixture consisting of glycopyrronium bromide, a muscarinic antagonist and indacaterol, a β-2 receptor agonist; used for maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease.
Last Modified18 January 2016
SubmitterSteve
Roles Classification
Application:
bronchodilator agent  An agent that causes an increase in the expansion of a bronchus or bronchial tubes.
ChEBI Ontology
Outgoing Relation(s)
Utibron Neohaler (CHEBI:90962) has part indacaterol maleate (CHEBI:68573)
Utibron Neohaler (CHEBI:90962) has part ritropirronium bromide (CHEBI:5494)
Utibron Neohaler (CHEBI:90962) has role bronchodilator agent (CHEBI:35523)
Utibron Neohaler (CHEBI:90962) is a mixture (CHEBI:60004)
Synonyms  Source
Indacaterol / glycopyrroniumChemIDplus
Glycopyrrolate mixture with indacaterolChEBI
Glycopyrronium bromide / indacaterolChemIDplus
QVA 149ChemIDplus
Glycopyrrolate / indacaterolChemIDplus
QVA149ChemIDplus
Brand Names  Source
UltibroKEGG DRUG
Utibron NeohalerKEGG DRUG
Glycopyrronium bromide - indacaterol maleate mixtKEGG DRUG
Manual XrefsDatabases
D10505KEGG DRUG
Registry NumbersSources
CAS:1262431-94-6ChemIDplus
Citations